Merck Foundation Marking “World Diabetes Day” by Providing out of 2080 Scholarships, 830 Scholarships for Diabetes and Hypertension in 52 Countries
Reading Time: 4 minutes Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks ‘World Diabetes Day 2024’ together with Africa’s First Ladies, Ministries of Health, Medical Societies and Academia, through their “Nationwide Diabetes & Hypertension Blue Points Program”. Senator, Dr. Rasha Kelej, CEO of Merck Foundation emphasized, “At Merck Foundation, we
Information about the Annual Report 2023/2024
Reading Time: 2 minutes Diamyd Medical today publishes its Annual Report for 2023/24. The Company is in an expansive phase where positive feedback has been received from the US Food and Drug Administration (FDA) regarding the possibility of earlier market approval. The Annual Report is published
20th Edition of Clean India Show Will Set the Stage for Tech-Enabled Clean Revolution for Professional Cleaning, Facility Management, Hygiene, Waste Management, Laundry and Auto Care Solutions – All Under One Roof
Reading Time: 3 minutes Mumbai, Maharashtra, India: India’s integrated expos for clean tech industry – Clean India Show along with concurrent shows – Waste Technology India Expo, LaundrexIndia Expo and AutoCare Expo, is scheduled from 21 – 23 November 2024 at Bombay Exhibition Centre, Mumbai. The
Ram Film Factory’s ‘Trending’ Tamil Movie to Hit Theatres This Month
Reading Time: 3 minutes Three more films are in the pipeline-the pre-production of one of them is completed, and script for another is finalised Ram Film Factory is launched by Ms. Meenakshi Anand, daughter-in-law of late Mr. K. Govindan, a celebrated costume designer
Bioretec Ltd’s business review January–September 2024: Launch of the RemeOs™ Trauma Screw in the U.S. is proceeding to the next phase, EU authorization in the final stage
Reading Time: 7 minutes Bioretec Ltd Company announcement 14 November 2024 at 8:45 a.m. This announcement summarizes Bioretec Ltd’s business review for January–September 2024. The complete business review is attached to this release as a PDF file and available on the company’s website at https://bioretec.com/investors/investors-in-english/releases. July
FedEx Economic Impact Report Showcases ‘FedEx Effect’ on Driving India’s Growth and Commitment to Sustainability
Reading Time: 3 minutes FedEx Corp. (NYSE: FDX) released its annual economic impact report, analyzing the company’s worldwide network and role in building prosperity in local communities during its 2024 fiscal year (FY 2024). Produced in consultation with Dun & Bradstreet (NYSE: DNB), a leading provider of business decisioning
US-listed company intends to make an offer to take over a minimum of 51% of the shares in DecideAct A/S and has signed LOI
Reading Time: 2 minutes DecideAct A/S [ACT] Company Announcement No. 10-2024: NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN DecideAct A/S (the Company) has signed a letter of intent (LOI) with the purpose to receive a binding offer from a US-listed company. The potential acquirer specializes in investing in SaaS companies
US-listed company intends to make an offer to take over a minimum of 51% of the shares in DecideAct A/S and has signed LOI
Reading Time: 2 minutes DecideAct A/S [ACT] NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN DecideAct A/S (the Company) has signed a letter of intent (LOI) with the purpose to receive a binding offer from a US-listed company. The potential acquirer specializes in investing in SaaS companies and wants to
Tecnotree Selected to Provide Multi-Tenant MVNE Platform and Moments Marketplace to Power Tier 1 MVNE in EMEA
Reading Time: 2 minutes Espoo, Finland: Tecnotree, a global digital Business Support Systems (BSS) provider and a leader in digital transformation solutions, has announced its latest collaboration with a leading MVNE in EMEA. This partnership will harness the multi-tenant capabilities of Tecnotree’s state-of-the-art MVNE platform
PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen
Reading Time: 3 minutes MUMBAI, India & HYDERABAD, India: PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using machine learning-enabled computational protein design, is pleased to announce that it has been selected for inclusion in the U.S. Government’s Project NextGen. As part